[
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Hsbc Holdings PLC Lowers Stock Holdings in GSK plc (NYSE:GSK)",
        "description":"Hsbc Holdings PLC lowered its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 5.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 3,552,119 shares of t\u2026",
        "content":"Hsbc Holdings PLC lowered its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 5.9% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commis\u2026 [+4481 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/19\/hsbc-holdings-plc-lowers-stock-holdings-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726760852000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9991538525,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Bokf Na Purchases 1,787 Shares of GSK plc (NYSE:GSK)",
        "description":"Bokf Na boosted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 20.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 10,389 shares of the pharmaceutical company\u2019s stock after buying an additional 1,787 shares during the period. Bokf Na\u2019s \u2026",
        "content":"Bokf Na boosted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 20.8% in the 2nd quarter, HoldingsChannel.com reports. The firm owned 10,389 shares of the pharmaceutical company\u2019s stock after buy\u2026 [+3954 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/17\/bokf-na-purchases-1787-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726571556000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9983282685,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Short Interest Up 13.1% in August",
        "description":"GSK plc (NYSE:GSK \u2013 Get Free Report) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 10,910,000 shares, an increase of 13.1% from the August 15th total of 9,650,000 shares. Approximate\u2026",
        "content":"GSK plc (NYSE:GSK \u2013 Get Free Report) saw a significant increase in short interest in the month of August. As of August 31st, there was short interest totalling 10,910,000 shares, an increase of 13.1%\u2026 [+3916 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/18\/gsk-plc-nysegsk-short-interest-up-13-1-in-august\/",
        "source":"ETF Daily News",
        "published_at":1726645619000,
        "collected_at":1727696503872,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9985522628,
        "sentiment_vector":0.9985522628
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"D.A. Davidson & CO. Trims Stock Position in GSK plc (NYSE:GSK)",
        "description":"D.A. Davidson & CO. reduced its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 20.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 104,571 shares of the pharmaceutical company\u2019s stock aft\u2026",
        "content":"D.A. Davidson &amp; CO. reduced its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 20.6% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fun\u2026 [+3732 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/d-a-davidson-co-trims-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725451656000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9997584224,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Ballentine Partners LLC Sells 3,015 Shares of GSK plc (NYSE:GSK)",
        "description":"Ballentine Partners LLC reduced its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 20.0% in the 2nd quarter, Holdings Channel.com reports. The fund owned 12,066 shares of the pharmaceutical company\u2019s stock after selling 3,015 shares during the peri\u2026",
        "content":"Ballentine Partners LLC reduced its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 20.0% in the 2nd quarter, Holdings Channel.com reports. The fund owned 12,066 shares of the pharmaceutica\u2026 [+4125 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/11\/ballentine-partners-llc-sells-3015-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726053428000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999778271,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Analysts Set GSK plc (NYSE:GSK) PT at $50.00",
        "description":"Shares of GSK plc (NYSE:GSK \u2013 Get Free Report) have received an average rating of \u201cModerate Buy\u201d from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Four equities research analysts have rated the stock with a hold rat\u2026",
        "content":"Shares of GSK plc (NYSE:GSK \u2013 Get Free Report) have received an average rating of \u201cModerate Buy\u201d from the nine brokerages that are presently covering the company, Marketbeat Ratings reports. Four equ\u2026 [+4034 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/07\/analysts-set-gsk-plc-nysegsk-pt-at-50-00\/",
        "source":"ETF Daily News",
        "published_at":1725688867000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.7871088386,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Shares Sold by ELCO Management Co. LLC",
        "description":"ELCO Management Co. LLC lowered its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 33.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 6,108 shares of the pharmaceu\u2026",
        "content":"ELCO Management Co. LLC lowered its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 33.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Excha\u2026 [+4973 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/25\/gsk-plc-nysegsk-shares-sold-by-elco-management-co-llc\/",
        "source":"ETF Daily News",
        "published_at":1727290626000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999994874,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Shares Bought by Dimensional Fund Advisors LP",
        "description":"Dimensional Fund Advisors LP boosted its position in shares of GSK plc (NYSE:GSK - Free Report) by 33.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owne\u2026",
        "content":"Dimensional Fund Advisors LP boosted its position in shares of GSK plc (NYSE:GSK - Free Report) by 33.8% in the second quarter, according to the company in its most recent 13F filing with the Securit\u2026 [+136 chars]",
        "url":"https:\/\/biztoc.com\/x\/febb95641c5aaeb8",
        "source":"Biztoc.com",
        "published_at":1727336156000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999771118,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Shares Sold by Financial Counselors Inc.",
        "description":"Financial Counselors Inc. trimmed its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 2.6% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor o\u2026",
        "content":"Financial Counselors Inc. trimmed its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 2.6% during the second quarter, according to the company in its most recent Form 13F filing with the Se\u2026 [+4588 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/03\/gsk-plc-nysegsk-shares-sold-by-financial-counselors-inc\/",
        "source":"ETF Daily News",
        "published_at":1725361130000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999836683,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Founders Financial Securities LLC Grows Position in GSK plc (NYSE:GSK)",
        "description":"Founders Financial Securities LLC raised its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 3.1% in the second quarter, Holdings Channel reports. The institutional investor owned 17,760 shares of the pharmaceutical company\u2019s stock after buying an addi\u2026",
        "content":"Founders Financial Securities LLC raised its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 3.1% in the second quarter, Holdings Channel reports. The institutional investor owned 17,760 share\u2026 [+3892 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/05\/founders-financial-securities-llc-grows-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725539568000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9954189062,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Caprock Group LLC Buys 13,943 Shares of GSK plc (NYSE:GSK)",
        "description":"Caprock Group LLC lifted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 115.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 26,000 shares of the pharmaceutical compan\u2026",
        "content":"Caprock Group LLC lifted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 115.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC\u2026 [+4282 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/11\/caprock-group-llc-buys-13943-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726059798000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9998745918,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Sei Investments Co. Acquires 24,658 Shares of GSK plc (NYSE:GSK)",
        "description":"Sei Investments Co. boosted its holdings in GSK plc (NYSE:GSK - Free Report) by 3.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 831,592 shares of the pharmaceutical company's stock\u2026",
        "content":"Sei Investments Co. boosted its holdings in GSK plc (NYSE:GSK - Free Report) by 3.1% in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fir\u2026 [+131 chars]",
        "url":"https:\/\/biztoc.com\/x\/fdcb11aa3d4167eb",
        "source":"Biztoc.com",
        "published_at":1727169126000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999951124,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Ritholtz Wealth Management Cuts Position in GSK plc (NYSE:GSK)",
        "description":"Ritholtz Wealth Management lessened its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 76,397 shares of the pharmaceutical company\u2019s stock after selling 1,147 shares during the period\u2026",
        "content":"Ritholtz Wealth Management lessened its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.5% in the 2nd quarter, HoldingsChannel reports. The fund owned 76,397 shares of the pharmaceutical \u2026 [+4007 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/02\/ritholtz-wealth-management-cuts-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725275961000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9998420477,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Shares Purchased by IFG Advisory LLC",
        "description":"IFG Advisory LLC lifted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 12.6% during the second quarter, HoldingsChannel.com reports. The fund owned 14,605 shares of the pharmaceutical company\u2019s stock after acquiring an additional 1,638 shares during the \u2026",
        "content":"IFG Advisory LLC lifted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 12.6% during the second quarter, HoldingsChannel.com reports. The fund owned 14,605 shares of the pharmaceutical company\u2019s \u2026 [+4397 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/02\/gsk-plc-nysegsk-shares-purchased-by-ifg-advisory-llc\/",
        "source":"ETF Daily News",
        "published_at":1725272327000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999750853,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Waters Parkerson & CO. LLC Buys 962 Shares of GSK plc (NYSE:GSK)",
        "description":"Waters Parkerson & CO. LLC grew its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 5.4% during the second quarter, Holdings Channel.com reports. The fund owned 18,780 shares of the pharmaceutical company\u2019s stock after purchasing an additional 962 s\u2026",
        "content":"Waters Parkerson &amp; CO. LLC grew its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 5.4% during the second quarter, Holdings Channel.com reports. The fund owned 18,780 shares of the pha\u2026 [+4692 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/20\/waters-parkerson-co-llc-buys-962-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726856229000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999271631,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"ProVise Management Group LLC Trims Stock Holdings in GSK plc (NYSE:GSK)",
        "description":"ProVise Management Group LLC cut its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.3% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 122,028 shares of the pharmaceutical \u2026",
        "content":"ProVise Management Group LLC cut its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.3% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchange \u2026 [+4180 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/20\/provise-management-group-llc-trims-stock-holdings-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726861764000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999939203,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Mount Yale Investment Advisors LLC Cuts Stock Position in GSK plc (NYSE:GSK)",
        "description":"Mount Yale Investment Advisors LLC cut its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 11.0% in the 2nd quarter, HoldingsChannel reports. The firm owned 17,052 shares of the pharmaceutical company\u2019s stock after selling 2,102 shares during the qu\u2026",
        "content":"Mount Yale Investment Advisors LLC cut its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 11.0% in the 2nd quarter, HoldingsChannel reports. The firm owned 17,052 shares of the pharmaceuti\u2026 [+4102 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/mount-yale-investment-advisors-llc-cuts-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727189288000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999966621,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Elizabeth (Liz) McKee Anderson Acquires 446 Shares of GSK plc (LON:GSK) Stock",
        "description":"GSK plc (LON:GSK \u2013 Get Free Report) insider Elizabeth (Liz) McKee Anderson bought 446 shares of the firm\u2019s stock in a transaction that occurred on Monday, September 23rd. The stock was bought at an average price of GBX 2,051 ($27.46) per share, with a total v\u2026",
        "content":"GSK plc (LON:GSK \u2013 Get Free Report) insider Elizabeth (Liz) McKee Anderson bought 446 shares of the firm\u2019s stock in a transaction that occurred on Monday, September 23rd. The stock was bought at an a\u2026 [+2838 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/24\/elizabeth-liz-mckee-anderson-acquires-446-shares-of-gsk-plc-longsk-stock\/",
        "source":"ETF Daily News",
        "published_at":1727206843000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999976158,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Summit Trail Advisors LLC Grows Stock Position in GSK plc (NYSE:GSK)",
        "description":"Summit Trail Advisors LLC lifted its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 37.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 7,473 shares of the pharmaceutical company\u2019s stock after buying an additional 2,027 shares durin\u2026",
        "content":"Summit Trail Advisors LLC lifted its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 37.2% in the 2nd quarter, Holdings Channel.com reports. The firm owned 7,473 shares of the pharmaceutical c\u2026 [+4675 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/25\/summit-trail-advisors-llc-grows-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727267674000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999232173,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Vanguard Personalized Indexing Management LLC Has $2.22 Million Stake in GSK plc (NYSE:GSK)",
        "description":"Vanguard Personalized Indexing Management LLC lifted its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 13.9% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned \u2026",
        "content":"Vanguard Personalized Indexing Management LLC lifted its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 13.9% in the second quarter, according to the company in its most recent 13F filing \u2026 [+4728 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/21\/vanguard-personalized-indexing-management-llc-has-2-22-million-stake-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726908095000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9998379946,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Stock Holdings Increased by Concurrent Investment Advisors LLC",
        "description":"Concurrent Investment Advisors LLC increased its holdings in GSK plc (NYSE:GSK \u2013 Free Report) by 16.3% during the second quarter, Holdings Channel reports. The firm owned 11,889 shares of the pharmaceutical company\u2019s stock after purchasing an additional 1,663\u2026",
        "content":"Concurrent Investment Advisors LLC increased its holdings in GSK plc (NYSE:GSK \u2013 Free Report) by 16.3% during the second quarter, Holdings Channel reports. The firm owned 11,889 shares of the pharmac\u2026 [+3891 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/gsk-plc-nysegsk-stock-holdings-increased-by-concurrent-investment-advisors-llc\/",
        "source":"ETF Daily News",
        "published_at":1725444295000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.995800674,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Bank of New York Mellon Corp Raises Stock Position in GSK plc (NYSE:GSK)",
        "description":"Bank of New York Mellon Corp lifted its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 8.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 926,517 shar\u2026",
        "content":"Bank of New York Mellon Corp lifted its position in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 8.1% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Com\u2026 [+4338 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/03\/bank-of-new-york-mellon-corp-raises-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725351915000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9962604642,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (LON:GSK) Receives Average Recommendation of \u201cModerate Buy\u201d from Brokerages",
        "description":"GSK plc (LON:GSK \u2013 Get Free Report) has been given an average recommendation of \u201cModerate Buy\u201d by the seven research firms that are currently covering the company, MarketBeat Ratings reports. One analyst has rated the stock with a sell rating, one has assigne\u2026",
        "content":"GSK plc (LON:GSK \u2013 Get Free Report) has been given an average recommendation of \u201cModerate Buy\u201d by the seven research firms that are currently covering the company, MarketBeat Ratings reports. One ana\u2026 [+2879 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/11\/gsk-plc-longsk-receives-average-recommendation-of-moderate-buy-from-brokerages\/",
        "source":"ETF Daily News",
        "published_at":1726035659000,
        "collected_at":1727696503872,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.5510320067,
        "sentiment_vector":0.5510320067
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Allspring Global Investments Holdings LLC Sells 5,187 Shares of GSK plc (NYSE:GSK)",
        "description":"Allspring Global Investments Holdings LLC cut its position in GSK plc (NYSE:GSK \u2013 Free Report) by 38.3% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 8,359 shares of the pharmaceutical company\u2019s stock after selling 5,187 s\u2026",
        "content":"Allspring Global Investments Holdings LLC cut its position in GSK plc (NYSE:GSK \u2013 Free Report) by 38.3% in the 2nd quarter, Holdings Channel.com reports. The institutional investor owned 8,359 shares\u2026 [+4412 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/07\/allspring-global-investments-holdings-llc-sells-5187-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725698452000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999804497,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Daymark Wealth Partners LLC Buys Shares of 25,675 GSK plc (NYSE:GSK)",
        "description":"Daymark Wealth Partners LLC bought a new stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 25,675 shares of the pharmaceutical comp\u2026",
        "content":"Daymark Wealth Partners LLC bought a new stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) during the second quarter, according to the company in its most recent filing with the SEC. The institutio\u2026 [+4726 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/28\/daymark-wealth-partners-llc-buys-shares-of-25675-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727548303000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999693632,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Crossmark Global Holdings Inc. Purchases 803 Shares of GSK plc (NYSE:GSK)",
        "description":"Crossmark Global Holdings Inc. boosted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned\u2026",
        "content":"Crossmark Global Holdings Inc. boosted its position in GSK plc (NYSE:GSK \u2013 Free Report) by 2.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and\u2026 [+4213 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/08\/31\/crossmark-global-holdings-inc-purchases-803-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725112625000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999862909,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Farther Finance Advisors LLC Has $232,000 Holdings in GSK plc (NYSE:GSK)",
        "description":"Farther Finance Advisors LLC raised its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 52.3% in the second quarter, Holdings Channel.com reports. The firm owned 6,057 shares of the pharmaceutical company\u2019s stock after buying an additional 2,081 shares\u2026",
        "content":"Farther Finance Advisors LLC raised its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 52.3% in the second quarter, Holdings Channel.com reports. The firm owned 6,057 shares of the pharmaceut\u2026 [+4417 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/06\/farther-finance-advisors-llc-has-232000-holdings-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725619727000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999390841,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Ashton Thomas Private Wealth LLC Makes New Investment in GSK plc (NYSE:GSK)",
        "description":"Ashton Thomas Private Wealth LLC purchased a new position in shares of GSK plc (NYSE:GSK \u2013 Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 952 shares\u2026",
        "content":"Ashton Thomas Private Wealth LLC purchased a new position in shares of GSK plc (NYSE:GSK \u2013 Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities \u2026 [+4761 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/17\/ashton-thomas-private-wealth-llc-makes-new-investment-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726567368000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999750853,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Oppenheimer & Co. Inc. Has $2.40 Million Position in GSK plc (NYSE:GSK)",
        "description":"Oppenheimer & Co. Inc. trimmed its position in GSK plc (NYSE:GSK \u2013 Free Report) by 6.3% during the second quarter, HoldingsChannel.com reports. The fund owned 62,441 shares of the pharmaceutical company\u2019s stock after selling 4,230 shares during the period. Op\u2026",
        "content":"Oppenheimer &amp; Co. Inc. trimmed its position in GSK plc (NYSE:GSK \u2013 Free Report) by 6.3% during the second quarter, HoldingsChannel.com reports. The fund owned 62,441 shares of the pharmaceutical \u2026 [+3948 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/17\/oppenheimer-co-inc-has-2-40-million-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726573886000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999921322,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (LON:GSK) Insider Elizabeth (Liz) McKee Anderson Buys 446 Shares",
        "description":"GSK plc (LON:GSK - Get Free Report) insider Elizabeth (Liz) McKee Anderson bought 446 shares of the business's stock in a transaction that occurred on Monday, September 23rd. The stock was purchased at an average cost of GBX 2,051 ($27.46) per share, for a to\u2026",
        "content":"GSK plc (LON:GSK - Get Free Report) insider Elizabeth (Liz) McKee Anderson bought 446 shares of the business's stock in a transaction that occurred on Monday, September 23rd. The stock was purchased \u2026 [+142 chars]",
        "url":"https:\/\/biztoc.com\/x\/d62e5b6c75abb2c1",
        "source":"Biztoc.com",
        "published_at":1727242452000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.999997735,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"First City Capital Management Inc. Cuts Stock Position in GSK plc (NYSE:GSK)",
        "description":"First City Capital Management Inc. decreased its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 18.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 8,708 shares of the pharmaceutical company\u2019s stock after sell\u2026",
        "content":"First City Capital Management Inc. decreased its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 18.6% during the second quarter, HoldingsChannel reports. The institutional investor owned 8\u2026 [+4264 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/22\/first-city-capital-management-inc-cuts-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727022047000,
        "collected_at":1727696503872,
        "sentiment_label":"Negative",
        "sentiment_probabolity":0.8938462734,
        "sentiment_vector":-0.8938462734
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Given Average Recommendation of \u201cModerate Buy\u201d by Analysts",
        "description":"Shares of GSK plc (NYSE:GSK \u2013 Get Free Report) have received an average rating of \u201cModerate Buy\u201d from the nine ratings firms that are covering the firm, MarketBeat.com reports. Four analysts have rated the stock with a hold rating, two have issued a buy ratin\u2026",
        "content":"Shares of GSK plc (NYSE:GSK \u2013 Get Free Report) have received an average rating of \u201cModerate Buy\u201d from the nine ratings firms that are covering the firm, MarketBeat.com reports. Four analysts have rat\u2026 [+3683 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/29\/gsk-plc-nysegsk-given-average-recommendation-of-moderate-buy-by-analysts\/",
        "source":"ETF Daily News",
        "published_at":1727592128000,
        "collected_at":1727696503872,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9981377125,
        "sentiment_vector":0.9981377125
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"GSK plc (NYSE:GSK) Given Average Recommendation of \"Moderate Buy\" by Brokerages",
        "description":"Shares of GSK plc (NYSE:GSK - Get Free Report) have been given an average recommendation of \"Moderate Buy\" by the nine brokerages that are covering the company, MarketBeat reports. Four equities research analysts have rated the stock with a hold recommendatio\u2026",
        "content":"Shares of GSK plc (NYSE:GSK - Get Free Report) have been given an average recommendation of \"Moderate Buy\" by the nine brokerages that are covering the company, MarketBeat reports. Four equities rese\u2026 [+135 chars]",
        "url":"https:\/\/biztoc.com\/x\/31a5c686d2cceb4e",
        "source":"Biztoc.com",
        "published_at":1727592763000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.8593819141,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Essex Financial Services Inc. Boosts Stock Position in GSK plc (NYSE:GSK)",
        "description":"Essex Financial Services Inc. increased its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 41.3% during the second quarter, HoldingsChannel reports. The institutional investor owned 7,234 shares of the pharmaceutical company\u2019s stock after acquiring\u2026",
        "content":"Essex Financial Services Inc. increased its holdings in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 41.3% during the second quarter, HoldingsChannel reports. The institutional investor owned 7,234 \u2026 [+4229 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/04\/essex-financial-services-inc-boosts-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1725449572000,
        "collected_at":1727696503872,
        "sentiment_label":"Positive",
        "sentiment_probabolity":0.9999915361,
        "sentiment_vector":0.9999915361
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Legacy Financial Advisors Inc. Has $319,000 Stock Position in GSK plc (NYSE:GSK)",
        "description":"Legacy Financial Advisors Inc. lifted its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 7.0% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 8,280 shares of the pharmaceutical company\u2019s \u2026",
        "content":"Legacy Financial Advisors Inc. lifted its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 7.0% during the 2nd quarter, according to its most recent 13F filing with the Securities &amp; Exchange Commissi\u2026 [+4166 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/22\/legacy-financial-advisors-inc-has-319000-stock-position-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727018808000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999835491,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Mesirow Financial Investment Management Inc. Sells 293 Shares of GSK plc (NYSE:GSK)",
        "description":"Mesirow Financial Investment Management Inc. reduced its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.8% during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 16,370 share\u2026",
        "content":"Mesirow Financial Investment Management Inc. reduced its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 1.8% during the 2nd quarter, according to its most recent disclosure with the Securitie\u2026 [+4285 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/18\/mesirow-financial-investment-management-inc-sells-293-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1726665298000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9998966455,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"AE Wealth Management LLC Acquires 815 Shares of GSK plc (NYSE:GSK)",
        "description":"AE Wealth Management LLC boosted its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 4.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 19,869 shares\u2026",
        "content":"AE Wealth Management LLC boosted its stake in shares of GSK plc (NYSE:GSK \u2013 Free Report) by 4.3% in the second quarter, according to the company in its most recent Form 13F filing with the Securities\u2026 [+4291 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/26\/ae-wealth-management-llc-acquires-815-shares-of-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727359295000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999802113,
        "sentiment_vector":0.0
    },
    {
        "company":"GSK plc",
        "ticker":"GSK",
        "title":"Susquehanna International Group Ltd. Has $2.03 Million Holdings in GSK plc (NYSE:GSK)",
        "description":"Susquehanna International Group Ltd. cut its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 8.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 52,697 shares of the pharmaceu\u2026",
        "content":"Susquehanna International Group Ltd. cut its stake in GSK plc (NYSE:GSK \u2013 Free Report) by 8.2% in the second quarter, according to the company in its most recent filing with the Securities and Exchan\u2026 [+5047 chars]",
        "url":"https:\/\/www.etfdailynews.com\/2024\/09\/28\/susquehanna-international-group-ltd-has-2-03-million-holdings-in-gsk-plc-nysegsk\/",
        "source":"ETF Daily News",
        "published_at":1727559954000,
        "collected_at":1727696503872,
        "sentiment_label":"Neutral",
        "sentiment_probabolity":0.9999784231,
        "sentiment_vector":0.0
    }
]